Our Focus

Digital Diagnostic Asia offers for each condition a set of tests that
are today the benchmark for non-invasive liver diagnostic.

Liver
Health


Virus, alcohol consumption and metabolic risk factors are the main causes of liver conditions. Digital Diagnostic Asia offers for each condition a set of tests that are today the benchmark for non-invasive liver diagnostic.

HCV
Hepatitis C

About 180 million people are infected with HCV. There are 6 genotypes, with a prevalence according to the geographic distribution. HCV infection becomes chronic in 60% to 80% of cases. The virological tests studied in cases of HCV are the anti-HCV antibodies, HCV-RNA, the viral load and genotype. Certain factors are associated with faster progression to cirrhosis: age, male sex, alcohol, HIV co-infection, necroinflammatory activity, steatosis, metabolic factors. HCV genotype and the viral load do not have an effect on the fibrosis progression speed. Viral C cirrhosis with or without associated hepatocellular carcinoma is one of the main indications of liver transplantation.

Our Test For HCV

HBV
Hepatitis B

About 300 million people have chronic HBV infection worldwide. There are two types of chronic HBV infection: one associated with the wild-type virus, which is diagnosed by the presence of the HBe antigen, and one associated with the mutant virus without HBe antigen. HBV infection becomes chronic in 80% to 90% of cases of mother-to-child transmission and in 5% to 10% of adult cases. The main virological tests studied in cases of HBV are the HBs antigen and the HBV viral load. The anti-HBs antibodies are used to verify the efficacy of the vaccination. Certain factors are associated with faster progression to cirrhosis: age, male sex, alcohol, HIV co-infection, necroinflammatory activity, steatosis and metabolic factors.

Our Test For HBV

NAFLD
Non-alcoholic
fatty liver disease

It is estimated that about 25% of the world population has hepatic steatosis related to the presence of at least one metabolic syndrome factor: diabetes, overweight, hypertriglyceridemia, hypercholesterolemia, hypertension. A small portion of these steatoses cases (less than 10%) may be complicated by necrosis and inflammation (NASH), fibrosis with risk of progression to cirrhosis and liver cancer.

Our Test For NAFLD

Cardio
Metabolic

Health


Digital Diagnostic Asia gives you evaluation of the risk of your cardiovascular disease by combining it with your liver state to subjects with metabolic disorders such as type-2 diabetes or dyslipidaemia.